ETIOLOGY AND PATHOGENESIS OF PNEUMONIA IN CHILDREN
DOI:
https://doi.org/10.55640/Keywords:
Pediatric pneumonia, etiology, pathogenesis, bacterial infections, viral infections, immune response, Streptococcus pneumoniae, respiratory tract infections, host defense mechanisms, pulmonary inflammation.Abstract
Pneumonia is a leading cause of morbidity and mortality among children worldwide, particularly in children under five years of age. It represents a complex clinical syndrome characterized by inflammation of the lung parenchyma, resulting from diverse infectious agents and a range of host immune responses. The etiology of pediatric pneumonia is multifactorial, including bacterial, viral, fungal, and, less commonly, parasitic pathogens. Streptococcus pneumoniae, Haemophilus influenzae type b, and respiratory syncytial virus (RSV) are the most frequently identified causative agents in different pediatric age groups. Understanding the pathogenesis of pneumonia requires an integrated view of microbial virulence factors, host immune mechanisms, and environmental determinants. In children, the immaturity of both innate and adaptive immunity plays a crucial role in susceptibility and disease severity. Pulmonary defense mechanisms, such as mucociliary clearance, alveolar macrophages, and local antibody responses, may be insufficient in young children, facilitating microbial invasion and inflammatory damage. Excessive or dysregulated immune responses can contribute to tissue injury, hypoxemia, and complications such as pleural effusion or sepsis. Environmental factors, including malnutrition, air pollution, and inadequate vaccination, further exacerbate risk. This article provides a comprehensive review of the etiological agents of pediatric pneumonia and the mechanisms underlying its pathogenesis. By examining the interplay between infectious agents and the developing immune system, it highlights opportunities for early prevention, timely diagnosis, and effective therapeutic interventions, which are essential to reducing the global burden of childhood pneumonia.
References
1.O’Brien, K. L., Wolfson, L. J., Watt, J. P., Henkle, E., Deloria-Knoll, M., McCall, N., ... & Mulholland, K. (2019). Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. The Lancet, 374(9693), 893–902.
2.Scott, J. A. G., Brooks, W. A., Peiris, J. S., Holtzman, D., & Mulholland, K. (2017). Pneumonia research to reduce childhood mortality in the developing world. The Lancet InfectiousDiseases, 17(3), e45–e54.
3.Chisti, M. J., Salam, M. A., Smith, J. H., Ahmed, T., Pietroni, M., & Ashraf, H. (2015). Nutritional status and childhood pneumonia: implications for prevention and treatment. Journal ofTropicalPediatrics, 61(6), 421–429.
4.Black, R. E., Victora, C. G., Walker, S. P., Bhutta, Z. A., Christian, P., de Onis, M., ... &Uauy, R. (2018). Maternal and child undernutrition and overweight in low-income and middle-income countries. The Lancet, 382(9890), 427–451.
5.World Health Organization. (2022). Pneumonia in children: causes and management. WHO Press.
6.Mandell, L. A., Wunderink, R. G., & Anzueto, A. (2019). Principles and Practice of Infectious Diseases. Elsevier.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

